Xirong Li
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Plasma linoelaidyl carnitine levels positively correlated with symptom improvement in olanzapine-treated first-episode drug-naïve schizophrenia.
Journal: Metabolomics : Official journal of the Metabolomic Society
Published: November 25, 2021
Kynurenine pathway metabolites and therapeutic response to olanzapine in female patients with schizophrenia: A longitudinal study.
Journal: CNS neuroscience & therapeutics
Published: October 05, 2021
Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study.
Journal: Current neuropharmacology
Published: August 31, 2021
Plasma Lysophosphatidylcholine and Lysophosphatidylethanolamine Levels Were Associated With the Therapeutic Response to Olanzapine in Female Antipsychotics-naïve First-episode Patients With Schizophrenia.
Journal: Frontiers in pharmacology
Published: July 02, 2021
Antioxidant Enzymes and Weight Gain in Drug-naive First-episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study.
Journal: Current neuropharmacology
Published: April 17, 2021
Prevalence, clinical correlates and IQ of suicidal ideation in drug naïve Chinese Han patients with major depressive disorder.
Journal: Journal of affective disorders
Published: June 22, 2018
Electroconvulsive Therapy-Induced Brain Structural and Functional Changes in Major Depressive Disorders: A Longitudinal Study.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: November 27, 2016
Changes in Problem-Solving Capacity and Association With Spontaneous Brain Activity After a Single Electroconvulsive Treatment in Major Depressive Disorder.
Journal: The journal of ECT
Published: August 08, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026